[{"Assets_0_Q2_USD":3285594000.0,"CommonStockSharesOutstanding_0_Q2_shares":250769906.0,"EarningsPerShareBasic_1_Q2_USD":0.07,"EarningsPerShareBasic_2_Q2_USD":1.08,"EarningsPerShareDiluted_1_Q2_USD":0.07,"EarningsPerShareDiluted_2_Q2_USD":1.06,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":447345000.0,"NetIncomeLoss_1_Q2_USD":17996000.0,"NetIncomeLoss_2_Q2_USD":265752000.0,"StockholdersEquity_0_Q2_USD":1671273000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":251635000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":250199000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":247521000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":246782000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20170728"}]